Caption Management, LLC Ab Cellera Biologics Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $460,919 - $685,368	50,100 Added 16.7%	350,100 $3.46 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $572,000 - $1.07 Million	100,000 Added 50.0%	300,000 $3.2 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $746,000 - $1.41 Million	100,000 Added 100.0%	200,000 $1.95 Million
Q4 2021 Feb 11, 2022	SELL	$12.99 - $17.73 $827,463 - $1.13 Million	-63,700 Reduced 38.91%	100,000 $1.43 Million
Q3 2021 Nov 12, 2021	BUY	$14.85 - $21.34 $1.49 Million - $2.13 Million	100,000 Added 156.99%	163,700 $3.28 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $1.29 Million - $2.18 Million	63,700 New	63,700 $1.4 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.